Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
February, 2026
February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728  
Arisa Chuklin, Thita Joy Chiasakul, and Noppacharn Uaprasert on Management of Thrombosis in Behçet’s Syndrome
Arisa Chuklin, Thita Joy Chiasakul/LinkedIn; Noppacharn Uaprasert/ISTH
Oct 18, 2025, 16:49

Arisa Chuklin, Thita Joy Chiasakul, and Noppacharn Uaprasert on Management of Thrombosis in Behçet’s Syndrome

Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:

”Anticoagulants and immunosuppressive therapy for thrombosis in Behçet’s syndrome: a systematic review and meta-analysis

By Arisa Chuklin, Thita Joy Chiasakul, and Noppacharn Uaprasert

• Context: Behçet’s syndrome is a systemic vasculitis often complicated by venous or arterial thrombosis, yet the optimal role of anticoagulation remains uncertain.
• Study: Across 20 studies (315 patients with disaggregated data), this meta-analysis compared relapse rates under immunosuppressives, anticoagulants, or both.
• Findings: Combination therapy markedly reduced thrombosis relapse (17.7%) versus immunosuppressives alone (43.7%) or anticoagulants alone (54.9%), supporting a dual-modality approach for vascular Behçet’s.

Read the article.”

Read the full article in JTH.

Article: Anticoagulants and immunosuppressive therapy for thrombosis in Behçet’s syndrome: a systematic review and meta-analysis

Authors: Arisa Chuklin, Thita Joy Chiasakul, Noppacharn Uaprasert

Arisa Chuklin, Thita Joy Chiasakul, and Noppacharn Uaprasert on Management of Thrombosis in Behçet’s Syndrome

Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.

anticoagulants Arisa Chuklin Behçet’s Syndrome Headlines Health Hematology Hemostasis Hemostasis Today immunosuppressives JTH Medicine Noppacharn Uaprasert Thita Joy Chiasakul thrombosis
NewsFeed